Paradigm Biocapital Advisors LP
CIK 1855655
13F filing for Q2 2026・No. 872
- Holdings
- US$5.34B
- Quarter change
- +US$446.3M
- Entries
- 28
- Net bought (estimate)
- −US$508.12M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 7
- Sold out 14
- Cut 7
- Added 12
- Corporate actions 0
- Unchanged 2
Largest holdings
28 stocks worth US$5.34B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INCCOM | Cut | 6,361,323 | US$1.19B | 22.31% |
| NUVLNUVALENT INCCOM | Added | 5,924,433 | US$731.67M | 13.70% |
| EDGEWISE THERAPEUTICS INCCOM | Added | 10,215,455 | US$415.05M | 7.77% |
| GENMAB A/SSPONSORED ADS | Added | 13,133,131 | US$360.77M | 6.76% |
| SYRESPYRE THERAPEUTICS INCCOM NEW | Added | 3,840,778 | US$340.98M | 6.38% |
| APGEAPOGEE THERAPEUTICS INCCOM | Added | 1,576,385 | US$209.23M | 3.92% |
| ORUKA THERAPEUTICS INCCOM | Cut | 2,144,526 | US$204.09M | 3.82% |
| TANGO THERAPEUTICS INCCOM | Added | 6,357,523 | US$198.74M | 3.72% |
| BLTEBELITE BIO INCSPONSORED ADS | Added | 1,232,877 | US$189.84M | 3.55% |
| ERASCA INCCOM | Cut | 9,550,000 | US$174.96M | 3.28% |
Sign in (free) to see its 28 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.